Virtus Investment Advisers, LLC
HARTFORD, CT · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 12, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$452.8M2026 Q3
Positions458
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.9.5%
What Changed This Quarter?
Top Holdings
MRNA
Moderna
1.4%
IOVA
Iovance Biotherapeutics
1.4%
REGN
Regeneron Pharmaceuticals
0.9%
GILD
Gilead Sciences
0.9%
AMGN
Amgen
0.9%
VRTX
Vertex Pharmaceuticals Inc
0.9%
OMER
Omeros
0.8%
INCY
Incyte
0.8%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.